Form 4 for AKTX Akari Therapeutics Plc
Accepted 2026-08-19 17:00:01 ET · period of report 2026-08-17 · accession 0001493152-26-039246 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-19 17:00 | 2026-08-17 | AKTX | Farag Kameel D. | Interim CFO | A - Grant | $7.52 | +1,728 | 23.3K | +8% | +$13.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | American Depositary Shares representing Ordinary Shares | 2026-08-17 | A | A | 1,728 | $7.52 | 23,309 | D | — | — | (F1) These American Depositary Shares represent restricted stock units ("RSUs"), with each such RSU representing the right to receive 80,000 ordinary shares with a par value of $0.000000005 per ordinary share. The RSUs will vest in full on September 15, 2026. |